Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Eur J Med Chem. 2013 May 30;66:114–121. doi: 10.1016/j.ejmech.2013.05.021

Figure 3. Effect of ff(D-nle)r-NH2 in Trp287.

Figure 3

Panel A) shows the overall structure of the kappa-OR, showing the binding model of ff(D-nle)r-NH2, relevant residues are labeled. B) and C) Comparison of the orientation of Trp in the presence of the antagonist crystallographic ligand, JDTic, shown in green, and the agonist tetrapeptide ff(D-nle)r-NH2, shown in gray.